Provided by Tiger Fintech (Singapore) Pte. Ltd.

iTeos Therapeutics

10.00
-0.0200-0.20%
Post-market: 10.000.00000.00%16:33 EDT
Volume:650.94K
Turnover:6.53M
Market Cap:382.74M
PE:-3.24
High:10.12
Open:10.02
Low:9.99
Close:10.02
Loading ...

iTeos Therapeutics price target lowered to $17 from $19 at Wells Fargo

TIPRANKS
·
06 Mar

Promising Developments and Strategic Updates Drive Buy Rating for iTeos Therapeutics

TIPRANKS
·
06 Mar

iTeos Therapeutics: Undervalued with Promising Pipeline and Strong Financial Position

TIPRANKS
·
06 Mar

iTeos Therapeutics Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.
·
06 Mar

BUZZ-iTeos Therapeutics rises after reporting narrower-than-expected quarterly loss

Reuters
·
06 Mar

Iteos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Iteos Therapeutics Inc expected to post a loss of $1.06 a share - Earnings Preview

Reuters
·
05 Mar

ITeos Therapeutics Q4 2024 GAAP EPS $(1.01) Beats $(1.06) Estimate, Cash Balance And Investment Balance Of $655M As Of December 31, 2024 Expected To Provide Runway Through 2027

Benzinga
·
05 Mar

Iteos Therapeutics Inc - Cash Balance of $655 Million Expected to Provide Runway Through 2027

THOMSON REUTERS
·
05 Mar

Iteos Therapeutics Inc Qtrly Net Loss of $1.01 per Basic and Diluted Share

THOMSON REUTERS
·
05 Mar

Iteos Therapeutics Inc Q4 Shr View $-1.06 -- Lseg Ibes Data

THOMSON REUTERS
·
05 Mar

Press Release: iTeos Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Dow Jones
·
05 Mar

iTeos Therapeutics Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Jan

All You Need to Know About iTeos Therapeutics (ITOS) Rating Upgrade to Buy

Zacks
·
14 Jan

iTeos Therapeutics Plans 2025 Data Presentation on Therapies

TIPRANKS
·
13 Jan

Iteos Therapeutics Inc - Eos-984 Phase 1 Monotherapy and Pd-1 Combination Data Expected in 2H25

THOMSON REUTERS
·
10 Jan

Iteos Therapeutics Inc - Cash Balance of $683.9 Million Expected to Provide Runway Through 2027

THOMSON REUTERS
·
10 Jan

Iteos Therapeutics Inc - Eos-215 Ind Submission Anticipated in 1Q25

THOMSON REUTERS
·
10 Jan

Iteos Announces 2025 Strategic Priorities and Anticipated Milestones

THOMSON REUTERS
·
10 Jan

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones

GlobeNewswire
·
10 Jan